The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.

Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, Banerjee G, Barbato C, Bonneville F, Brandner S, Calviere L, Caparros F, Casolla B, Cordonnier C, Delisle MB, Deramecourt V, Dichgans M, Gokcal E, Herms J, Hernandez-Guillamon M, Jäger HR, Jaunmuktane Z, Linn J, Martinez-Ramirez S, Martínez-Sáez E, Mawrin C, Montaner J, Moulin S, Olivot JM, Piazza F, Puy L, Raposo N, Rodrigues MA, Roeber S, Romero JR, Samarasekera N, Schneider JA, Schreiber S, Schreiber F, Schwall C, Smith C, Szalardy L, Varlet P, Viguier A, Wardlaw JM, Warren A, Wollenweber FA, Zedde M, van Buchem MA, Gurol ME, Viswanathan A, Al-Shahi Salman R, Smith EE, Werring DJ, Greenberg SM

Open source

DOI: 10.1016/s1474-4422(22)00208-3
Published: 2022 Aug
Container: The Lancet. Neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-22-00208-3,
  title = {The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.},
  author = {Charidimou A and Boulouis G and Frosch MP and Baron JC and Pasi M and Albucher JF and Banerjee G and Barbato C and Bonneville F and Brandner S and Calviere L and Caparros F and Casolla B and Cordonnier C and Delisle MB and Deramecourt V and Dichgans M and Gokcal E and Herms J and Hernandez-Guillamon M and Jäger HR and Jaunmuktane Z and Linn J and Martinez-Ramirez S and Martínez-Sáez E and Mawrin C and Montaner J and Moulin S and Olivot JM and Piazza F and Puy L and Raposo N and Rodrigues MA and Roeber S and Romero JR and Samarasekera N and Schneider JA and Schreiber S and Schreiber F and Schwall C and Smith C and Szalardy L and Varlet P and Viguier A and Wardlaw JM and Warren A and Wollenweber FA and Zedde M and van Buchem MA and Gurol ME and Viswanathan A and Al-Shahi Salman R and Smith EE and Werring DJ and Greenberg SM},
  year = {2022},
  journal = {The Lancet. Neurology},
  doi = {10.1016/s1474-4422(22)00208-3},
  url = {https://doi.org/10.1016/s1474-4422(22)00208-3}
}

RIS

TY  - JOUR
TI  - The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
AU  - Charidimou A
AU  - Boulouis G
AU  - Frosch MP
AU  - Baron JC
AU  - Pasi M
AU  - Albucher JF
AU  - Banerjee G
AU  - Barbato C
AU  - Bonneville F
AU  - Brandner S
AU  - Calviere L
AU  - Caparros F
AU  - Casolla B
AU  - Cordonnier C
AU  - Delisle MB
AU  - Deramecourt V
AU  - Dichgans M
AU  - Gokcal E
AU  - Herms J
AU  - Hernandez-Guillamon M
AU  - Jäger HR
AU  - Jaunmuktane Z
AU  - Linn J
AU  - Martinez-Ramirez S
AU  - Martínez-Sáez E
AU  - Mawrin C
AU  - Montaner J
AU  - Moulin S
AU  - Olivot JM
AU  - Piazza F
AU  - Puy L
AU  - Raposo N
AU  - Rodrigues MA
AU  - Roeber S
AU  - Romero JR
AU  - Samarasekera N
AU  - Schneider JA
AU  - Schreiber S
AU  - Schreiber F
AU  - Schwall C
AU  - Smith C
AU  - Szalardy L
AU  - Varlet P
AU  - Viguier A
AU  - Wardlaw JM
AU  - Warren A
AU  - Wollenweber FA
AU  - Zedde M
AU  - van Buchem MA
AU  - Gurol ME
AU  - Viswanathan A
AU  - Al-Shahi Salman R
AU  - Smith EE
AU  - Werring DJ
AU  - Greenberg SM
PY  - 2022
JO  - The Lancet. Neurology
DO  - 10.1016/s1474-4422(22)00208-3
UR  - https://doi.org/10.1016/s1474-4422(22)00208-3
ER  -

APA

A, C., G, B., MP, F., JC, B., M, P., JF, A., G, B., C, B., F, B., S, B., L, C., F, C., B, C., C, C., MB, D., V, D., M, D., E, G., J, H., M, H., HR, J., Z, J., J, L., S, M., E, M., C, M., J, M., S, M., JM, O., F, P., L, P., N, R., MA, R., S, R., JR, R., N, S., JA, S., S, S., F, S., C, S., C, S., L, S., P, V., A, V., JM, W., A, W., FA, W., M, Z., MA, V. B., ME, G., A, V., R, A. S., EE, S., DJ, W., & SM, G. (2022). The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(22)00208-3

Source records

pubmed · retrieved 2026-09-26T15:59:30.796Z